CARLTON TECHNOLOGIES LIMITED

Company number 03452530 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: D+

Explanation: Carlton Technologies Limited is suffering from a severe case of "liquidity anemia." While the company possesses a substantial underlying asset base—primarily freehold property—that keeps it technically solvent on paper, its day-to-day circulatory system (cash flow and working capital) is critically impaired. The business owes significantly more in short-term debts than it can liquidate quickly, and its cash reserves have practically evaporated. Without immediate intervention, the company is at high risk of financial cardiac arrest (insolvency).


1. Key Vital Signs

  • Cash Reserves (The Pulse): £2,583 (Down 93.6% from £40,619 in 2023) The patient's pulse is dangerously weak. A wholesale business with over £600k in debtors and nearly £370k in stock operating on just £2.5k in the bank is living on the edge of cardiac arrest. This drastic drop in cash indicates the business is burning through its liquid reserves to service obligations.

  • Working Capital (Blood Pressure): -£226,976 (Current Assets £646k vs. Current Liabilities £873k) This is the most alarming symptom. A healthy business should have positive working capital—meaning it can comfortably pay its near-term bills. Currently, Carlton Technologies’ current liabilities exceed its current assets by over £226k. This negative working capital means the company is functionally insolvent on a day-to-day basis unless creditors are willing to wait for payment.

  • Net Assets (Body Mass Index): £279,871 (Down from £345,378 in 2023) On the surface, a positive net asset figure looks healthy, but the patient is losing weight rapidly. The £65k drop in net assets corresponds directly with a £65k drop in retained earnings (from £280,799 to £215,292), confirming that the business sustained a significant loss in 2024. The "body mass" is propped up entirely by a 2021 property revaluation (£990k) rather than trading strength.

  • Leverage & Debt Profile (Cholesterol Levels): High Risk Total liabilities stand at £873k against total assets of £646k. However, the asset figure is heavily skewed by £1.14m in tangible fixed assets (the property). The company has £350k in long-term bank loans and is heavily reliant on short-term creditor financing (acting as blocked arteries), which is putting immense pressure on the business's cash flow.


2. Diagnosis

Acute Liquidity Distress masked by Property Equity

The financial data reveals a business that is asset-rich but cash-poor. The core trading operation is hemorrhaging cash, as evidenced by the sharp decline in retained earnings and the near-zero cash balance.

The company's lifeblood is currently being sustained by its creditors (suppliers) and the inherent value of its freehold property. However, you cannot pay a supplier with a brick from the warehouse wall. The reliance on short-term debt to finance operations, combined with a shrinking cash base, suggests that the underlying wholesale business is experiencing severe trading difficulties or margin compression.

The reduction in staff from 10 to 9, alongside the drop in stock (from £541k to £367k) and debtors (from £411k to £275k), points to a contraction in business volume. While reducing stock can be a healthy diet for an bloated business, doing so without replenishing cash reserves indicates that stock is being sold off to plug cash flow gaps rather than being part of a strategic turnaround.


3. Recommendations

To stabilize the patient and restore financial wellness, the following immediate interventions are required:

  1. Emergency Cash Transfusion: The directors (the Crampton family) must urgently inject capital into the business. This could be through director loans or external long-term financing secured against the freehold property. The property revaluation in 2021 shows significant equity that could be unlocked to pay down pressing short-term creditors and provide a cash buffer.
  2. Debt Restructuring (Arterial Bypass): The company must renegotiate terms with its short-term creditors. Extending payment terms from 30 to 60 or 90 days will relieve immediate pressure on cash flow. Additionally, moving some of the short-term debt to long-term bank loans will help resolve the negative working capital ratio.
  3. Working Capital Diet (Asset Liquidation): While stock has already decreased, the remaining £367k in inventory needs rigorous review. Slow-moving or obsolete stock should be heavily discounted and converted to cash. Similarly, the £275k owed by debtors needs aggressive collection; every day that money is tied up in invoices is a day the company struggles to breathe.
  4. Review Operational Viability: The 2024 trading loss must be investigated. The directors need to assess whether the contraction in the business is a temporary market dip or a fundamental flaw in the current business model. A rapid pivot in pricing strategy or cost-cutting measures is necessary to ensure the business returns to profitability.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 28 July 2026